| Sign In to gain access to subscriptions and/or personal tools. |
Elemental Mercury Vapour Toxicity: Treatment and Levels in Plasma and UrineLaboratoire de Biochimie-Toxicologie, Hôpital Fernand Widal, 200 rue du Faubourg, Saint-Denis, 75010 Paris, France
Laboratoire de Biochimie-Toxicologie, Hôpital Fernand Widal, 200 rue du Faubourg, Saint-Denis, 75010 Paris, France
Reanimation Toxicologique, Hôpital Fernand Widal, 200 rue du Faubourg, Saint-Denis, 75010 Paris, France
Laboratoire de Biochimie-Toxicologie, Hôpital Fernand Widal, 200 rue du Faubourg, Saint-Denis, 75010 Paris, France 1 We report two cases of acute mercury vapour intoxication in humans. The mercury vapour was released from smelting alloys (gold-mercury amalgam). The alloy was apparently contaminated with an unknown amount of mercury. 2 Within half an hour of the incident, the victims began having moderate headache, nausea, lumbar pain and shortness of breath at rest. The patients were treated with BAL (2,3 dimercaptopropanol), followed by DMSA (2,3 dimercaptosuccinic acid). 3 Serial measurements of mercury metal in plasma and in urine were made for ten days. 4 The results suggest that in spite of the treatment, relatively high concentrations of mercury remain in the plasma for a very long time, and this could be explained by the progressive release of mercury from red blood cells and tissues after oxidation. However, BAL and DMSA did not seem to be the most efficient antidotes. They reduce the piasma inorganic mercury uptake at concentrations of <50 µg l-1.
Human & Experimental Toxicology, Vol. 13, No. 12,
848-852 (1994) |
|||